Inari Medical Reports Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Inari Medical Inc. (NARI) PT Lowered to $108 at Morgan Stanley
February 24, 2022 8:55 AM ESTMorgan Stanley analyst Cecilia Furlong lowered the price target on Inari Medical Inc. (NASDAQ: NARI) to $108.00 (from $119.00) while maintaining a Overweight rating.
... MoreInari Medical, Inc. (NARI) Misses Q4 EPS by 1c
February 23, 2022 4:54 PM ESTInari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of $0.02, $0.01 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $83.2 million versus the consensus estimate of $78.16 million.
For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.
... More